Financial News
Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )
0.6950
+0.0350
(+5.30%)
Streaming Delayed Price
Updated: 12:58 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Biora Therapeutics, Inc. - Common Stock
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics to Submit Updated IND Application for BT-600
October 23, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Medicine_3.jpeg?width=1200&height=800&fit=crop)
Robot Pills: A Game-Changer In Drug Delivery, With Potential Stock Upside
September 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Biora Therapeutics Q1 Earnings
May 15, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Biora Therapeutics
May 12, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/penny1600.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
September 19, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/13/motorcar_parts_of_america__-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/13/stock_market_2_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_11271.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.